Search results

Found 245 pages
AUTHOR: Katrina Megget

Results per page

10 20 50 100

Sort by

Relevance Date

7 Oct 2008:

Avastin/Tarceva combo does not improve survival

Genentech and OSI Pharmaceuticals have announced the combination treatment of Avastin (bevacizumab) with Tarceva (erlotinib) has not shown to improve survival in a Phase III study. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/avastintarceva_combo_does_not_improve_survival_986661

17 Aug 2012:

Idenix HCV drug put on hold

Shares in Idenix have plummeted about 40% after news US regulators have placed a partial hold on the company’s experimental hepatitis C drug IDX184 following safety concerns. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/idenix_hcv_drug_put_on_hold_976778

10 Sep 2009:

Pharma partly to blame for healthcare woes

As many as 84% of Americans blame the pharmaceutical industry for the country’s healthcare woes, a new survey has found. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/pharma_partly_to_blame_for_healthcare_woes_983672

4 Sep 2008:

Multaq cuts risk of stroke by a third

Sanofi-aventis’ potential blockbuster Multaq (dronedarone) has been shown to reduce the risk of stroke by more than a third in patients with an irregular heartbeat. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/multaq_cuts_risk_of_stroke_by_a_third_987934

4 Jan 2013:

Wellcome Trust launches investment arm

The UK-based Wellcome Trust has launched the new evergreen investment company Syncona Partners to provide capital to life science start-ups. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/wellcome_trust_launches_investment_arm_1004167

20 Aug 2010:

Date rape drug being considered by FDA

Despite GHB being a popular date rape drug, the US Food andDrug Administration has revealed it believes it to be effective in treatingfibromyalgia, say documents released ahead of today’s marketing review. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/date_rape_drug_being_considered_by_fda_982567

18 Sep 2008:

UK’s online research archive gets a facelift

The UK’s version of a digital archive of peer-reviewed research papers will be further developed after getting a cash injection of £1.3 million. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/uks_online_research_archive_gets_a_facelift_987837

13 Aug 2009:

Woodcock investigated for conflict of interest

The US Food and Drug Administration’s Janet Woodcock is under investigation for an alleged conflict of interest involving two generic drugmakers and approval of their drugs. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/woodcock_investigated_for_conflict_of_interest_983825

12 Apr 2012:

Takeda buys gout company URL Pharma

Takeda has forked out $800 million to acquire US-based gout specialist URL Pharma in its bid to expand in the states – however, some analysts have found the deal baffling. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/takeda_buys_gout_company_url_pharma_977500

2 Nov 2012:

Hurricane Sandy destroys medical research

Thousands of genetically engineered lab mice and years of research are believed to be the latest casualties following the fierce Hurricane Sandy that hit East Coast America this week. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/hurricane_sandy_destroys_medical_research_976316